Neomycin Sulfate
Get a Quick Quote Now
Select Packaging
Product Description
Product
Neomycin Sulfate
CAS
1405-10-3
Formula
H2-O4-S.x-Unspecified
Synonym
Neomycin, sulfate (salt); Biosol (Veterinary), Bykomycin, Caswell No. 595A, EINECS 215-773-1, EPA Pesticide Chemical Code 006313, Fradiomycin sulfate, Lidamycin creme, Mycaifradin sulfate, Mycifradin, Mycifradin-N, Mycigient, Myciguent, Neo-fradin, Neo-mantle creme, Neo-RX, Neobiotic, Neofracin, Neomix, Neomix (Veterinary), Neomycin sulfate, Neomycin sulphate, Neomycine sulfate, Neomycins sulfate, Neovet 325, New France F, Otobiotic, Quintess-N, UNII-057Y626693, USAF CB-19
Typical Product Specifications
Assay/Purity
Typically NLT 98%
Chemical Structure
Notes
Neomycin Sulfate is classified as an: Active Pharmaceutical Ingredient (API) / Pharmaceutical Intermediate
SMILES: O([C,H]1[C,H](O[C,H]2[C,,H]([C,H](O[C,,H]3O[C,H]([C,,H](O)[C,,H]([C,H]3N)O)CN)[C,H](O2)CO)O)[C,H]([C,H](N)C[C,,H]1N)O)[C,H]1O[C,,H]([C,,H](O)[C,,H]([C,H]1N)O)CN.S(O)(O)(=O)=O
SMILES: O([C,H]1[C,H](O[C,H]2[C,,H]([C,H](O[C,,H]3O[C,H]([C,,H](O)[C,,H]([C,H]3N)O)CN)[C,H](O2)CO)O)[C,H]([C,H](N)C[C,,H]1N)O)[C,H]1O[C,,H]([C,,H](O)[C,,H]([C,H]1N)O)CN.S(O)(O)(=O)=O
Class
Toxic Release Inventory (TRI) Chemicals , API Product List , Active Pharmaceutical Ingredients (API) & Intermediates
Industry
Neomycin Sulfate
Product Description
Product
Neomycin Sulfate
CAS
1405-10-3
Formula
H2-O4-S.x-Unspecified
Synonym
Neomycin, sulfate (salt); Biosol (Veterinary), Bykomycin, Caswell No. 595A, EINECS 215-773-1, EPA Pesticide Chemical Code 006313, Fradiomycin sulfate, Lidamycin creme, Mycaifradin sulfate, Mycifradin, Mycifradin-N, Mycigient, Myciguent, Neo-fradin, Neo-mantle creme, Neo-RX, Neobiotic, Neofracin, Neomix, Neomix (Veterinary), Neomycin sulfate, Neomycin sulphate, Neomycine sulfate, Neomycins sulfate, Neovet 325, New France F, Otobiotic, Quintess-N, UNII-057Y626693, USAF CB-19
Typical Product Specifications
Assay/Purity
Typically NLT 98%
Chemical Structure
Notes
Neomycin Sulfate is classified as an: Active Pharmaceutical Ingredient (API) / Pharmaceutical Intermediate
SMILES: O([C,H]1[C,H](O[C,H]2[C,,H]([C,H](O[C,,H]3O[C,H]([C,,H](O)[C,,H]([C,H]3N)O)CN)[C,H](O2)CO)O)[C,H]([C,H](N)C[C,,H]1N)O)[C,H]1O[C,,H]([C,,H](O)[C,,H]([C,H]1N)O)CN.S(O)(O)(=O)=O
SMILES: O([C,H]1[C,H](O[C,H]2[C,,H]([C,H](O[C,,H]3O[C,H]([C,,H](O)[C,,H]([C,H]3N)O)CN)[C,H](O2)CO)O)[C,H]([C,H](N)C[C,,H]1N)O)[C,H]1O[C,,H]([C,,H](O)[C,,H]([C,H]1N)O)CN.S(O)(O)(=O)=O
Class
Toxic Release Inventory (TRI) Chemicals , API Product List , Active Pharmaceutical Ingredients (API) & Intermediates
Industry
